The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to
the Securities and Exchange Commission (SEC)
by insider Baskett Forest since year 2005.
The trader's CIK number is 1277631.
At the time of this reporting, Baskett Forest is the 10% Owner of Adaptimmune Therapeutics Plc .
(stock ticker symbol ADAP).
See this page for all insider trading activities at Adaptimmune Therapeutics Plc .
| Trade Date | Symbol | Company Name (Issuer) | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|---|
| 2018-09-07 | ADAP | Adaptimmune Therapeutics Plc | Buy | 15,000,000 | 1.67 | 25,005,000 |
| 2018-08-21 | AVEO | Aveo Pharmaceuticals Inc | Buy | 663,716 | 2.26 | 1,499,998 |
| 2018-07-30 | LQDA | Liquidia Technologies Inc | Buy | 545,455 | 11.00 | 6,000,005 |
| 2018-07-18 | AVEO | Aveo Pharmaceuticals Inc | Buy | 200,000 | 1.95 | 390,600 |
| 2018-07-19 | AVEO | Aveo Pharmaceuticals Inc | Buy | 50,600 | 2.00 | 101,149 |
| 2018-06-27 | AVEO | Aveo Pharmaceuticals Inc | Buy | 5,295 | 2.15 | 11,384 |
| 2018-06-28 | AVEO | Aveo Pharmaceuticals Inc | Buy | 187,130 | 2.10 | 392,785 |
| 2018-05-30 | AVEO | Aveo Pharmaceuticals Inc | Buy | 275 | 2.15 | 591 |
| 2018-05-08 | AVEO | Aveo Pharmaceuticals Inc | Buy | 70,873 | 2.13 | 151,242 |
| 2018-04-23 | SURF | Surface Oncology, Inc. | Buy | 133,333 | 15.00 | 1,999,995 |
| 2018-04-06 | AVEO | Aveo Pharmaceuticals Inc | Buy | 685,676 | 2.24 | 1,537,285 |
| 2018-04-09 | AVEO | Aveo Pharmaceuticals Inc | Buy | 32,100 | 2.43 | 78,099 |
| 2018-04-10 | AVEO | Aveo Pharmaceuticals Inc | Buy | 203,200 | 2.46 | 500,075 |
| 2018-03-27 | ADAP | Adaptimmune Therapeutics Plc | Buy | 6,000,000 | 1.92 | 11,502,000 |
| 2018-03-26 | ADAP | Adaptimmune Therapeutics Plc | Buy | 571,164 | 1.90 | 1,087,496 |
| 2018-03-22 | ADAP | Adaptimmune Therapeutics Plc | Buy | 869,574 | 1.90 | 1,655,668 |
| 2018-03-23 | ADAP | Adaptimmune Therapeutics Plc | Buy | 294,090 | 1.95 | 572,299 |
| 2018-03-21 | ADAP | Adaptimmune Therapeutics Plc | Buy | 104,844 | 1.81 | 189,872 |
| 2018-03-06 | TSRO | Tesaro, Inc. | Buy | 15,793 | 59.81 | 944,658 |
| 2018-03-05 | TSRO | Tesaro, Inc. | Buy | 61,437 | 59.06 | 3,628,714 |
| 2018-03-02 | TSRO | Tesaro, Inc. | Buy | 68,302 | 55.83 | 3,813,573 |
| 2018-02-26 | ABIO | Arca Biopharma, Inc. | Sale | 1,460,209 | .50 | 731,564 |
| 2017-11-27 | APPN | Appian Corp | Sale | 569,620 | 19.49 | 11,101,893 |
| 2017-11-20 | APPN | Appian Corp | Sale | 2,820,516 | 19.49 | 54,971,856 |
| 2017-10-10 | RYTM | Rhythm Pharmaceuticals, Inc. | Buy | 550,000 | 17.00 | 9,350,000 |
| 2017-08-30 | ARDX | Ardelyx, Inc. | Sale | 485 | 4.95 | 2,400 |
| 2017-07-03 | MRSN | Mersana Therapeutics, Inc. | Buy | 1,000,000 | 15.00 | 15,000,000 |
| 2017-03-28 | AVEO | Aveo Pharmaceuticals Inc | Buy | 6,000,000 | .50 | 3,000,000 |
| 2017-03-27 | ADAP | Adaptimmune Therapeutics Plc | Buy | 12,870,000 | .70 | 9,009,000 |
| 2016-12-19 | AKAO | Achaogen Inc | Buy | 500,000 | 13.50 | 6,750,000 |
| 2016-12-05 | DATA | Tableau Software Inc | Sale | 10,833 | 45.66 | 494,656 |
| 2016-12-05 | DATA | Tableau Software Inc | Sale | 10,833 | 45.66 | 494,656 |
| 2016-11-29 | TCON | Tracon Pharmaceuticals, Inc. | Buy | 869,565 | 5.75 | 4,999,998 |
| 2016-10-31 | RARX | Ra Pharmaceuticals, Inc. | Buy | 338,462 | 13.00 | 4,400,006 |
| 2016-10-31 | RARX | Ra Pharmaceuticals, Inc. | Sale | 435 | 13.00 | 5,655 |
| 2016-07-29 | ILIU | Interleukin Genetics Inc | Buy | 20,120,724 | .10 | 1,991,951 |
| 2016-07-18 | ARDX | Ardelyx, Inc. | Buy | 2,290,951 | 8.73 | 20,000,002 |
| 2016-06-07 | DATA | Tableau Software Inc | Sale | 73,200 | 55.15 | 4,036,614 |
| 2016-03-18 | TSRO | Tesaro, Inc. | Buy | 1,420,858 | 35.19 | 49,999,993 |
| 2016-01-13 | ARDX | Ardelyx, Inc. | Buy | 1,500,000 | 10.00 | 15,000,000 |
| 2016-01-12 | EPZM | Epizyme, Inc. | Buy | 1,111,111 | 9.00 | 9,999,999 |
| 2015-11-24 | DATA | Tableau Software Inc | Sale | 26,667 | 93.97 | 2,505,924 |
| 2015-10-06 | MIRN | Synlogic, Inc. | Buy | 857,142 | 7.00 | 5,999,994 |
| 2015-06-17 | SUPN | Supernus Pharmaceuticals Inc | Sale | 111,881 | 16.35 | 1,828,918 |
| 2015-06-16 | SUPN | Supernus Pharmaceuticals Inc | Sale | 111,464 | 16.85 | 1,878,056 |
| 2015-06-05 | ARDX | Ardelyx, Inc. | Buy | 4,672,897 | 10.70 | 49,999,997 |
| 2015-06-02 | TSRO | Tesaro, Inc. | Sale | 2,562 | 57.74 | 147,919 |
| 2015-02-11 | DATA | Tableau Software Inc | Sale | 10,500 | 96.00 | 1,008,000 |
| 2015-02-04 | TCON | Tracon Pharmaceuticals, Inc. | Buy | 500,000 | 10.00 | 5,000,000 |
| 2014-12-23 | ILIU | Interleukin Genetics Inc | Buy | 19,868,965 | .10 | 1,986,896 |
| 2014-12-26 | ARDX | Ardelyx, Inc. | Sale | 1,972 | 21.28 | 41,960 |
| 2014-12-05 | DATA | Tableau Software Inc | Sale | 17,123 | 81.76 | 1,400,027 |
| 2014-12-04 | DATA | Tableau Software Inc | Sale | 34,786 | 81.05 | 2,819,300 |
| 2014-12-03 | DATA | Tableau Software Inc | Sale | 17,633 | 81.47 | 1,436,648 |
| 2014-10-08 | DERM | Dermira, Inc. | Buy | 69,112 | 16.00 | 1,105,792 |
| 2014-08-28 | SNSS | Sunesis Pharmaceuticals Inc | Sale | 146,800 | 7.87 | 1,154,875 |
| 2014-08-29 | SNSS | Sunesis Pharmaceuticals Inc | Sale | 11,600 | 7.51 | 87,069 |
| 2014-08-27 | SNSS | Sunesis Pharmaceuticals Inc | Sale | 108,300 | 8.17 | 884,811 |
| 2014-08-25 | DATA | Tableau Software Inc | Sale | 7,099 | 60.40 | 428,772 |
| 2014-08-22 | DATA | Tableau Software Inc | Sale | 52,312 | 60.74 | 3,177,430 |
| 2014-08-21 | DATA | Tableau Software Inc | Sale | 30,000 | 59.49 | 1,784,700 |
| 2014-08-15 | CVT | Cvent Inc | Sale | 3,075 | 26.11 | 80,272 |
| 2014-08-15 | EPZM | Epizyme, Inc. | Sale | 3,970 | 36.81 | 146,119 |
| 2014-08-08 | SNSS | Sunesis Pharmaceuticals Inc | Sale | 675,000 | 6.62 | 4,468,500 |
| 2014-08-12 | SNSS | Sunesis Pharmaceuticals Inc | Sale | 35,540 | 6.76 | 240,179 |
| 2014-08-06 | LOXO | Loxo Oncology, Inc. | Buy | 230,769 | 13.00 | 2,999,997 |
| 2014-07-22 | ROKA | Roka Bioscience, Inc. | Buy | 383,333 | 12.00 | 4,599,996 |
| 2014-06-06 | HPTX | Hyperion Therapeutics Inc | Sale | 1,377 | 26.89 | 37,022 |
| 2014-03-05 | DATA | Tableau Software Inc | Sale | 35,000 | 94.81 | 3,318,420 |
| 2014-03-07 | DATA | Tableau Software Inc | Sale | 23,624 | 91.58 | 2,163,485 |
| 2014-03-05 | DATA | Tableau Software Inc | Sale | 30,194 | 95.00 | 2,868,520 |
| 2014-03-06 | DATA | Tableau Software Inc | Sale | 50,000 | 95.29 | 4,764,300 |
| 2014-03-03 | DATA | Tableau Software Inc | Sale | 30,000 | 95.57 | 2,867,040 |
| 2014-03-04 | DATA | Tableau Software Inc | Sale | 10,804 | 97.31 | 1,051,369 |
| 2014-02-26 | DATA | Tableau Software Inc | Sale | 60,385 | 96.01 | 5,797,624 |
| 2014-02-27 | DATA | Tableau Software Inc | Sale | 118,756 | 95.95 | 11,395,231 |
| 2014-01-21 | CVT | Cvent Inc | Sale | 169,887 | 35.50 | 6,030,988 |
| 2014-01-16 | CVT | Cvent Inc | Sale | 1,132,589 | 35.50 | 40,206,909 |
| 2013-12-03 | ADNC | Audience Inc | Sale | 880 | 10.00 | 8,800 |
| 2013-11-21 | ADNC | Audience Inc | Sale | 106,615 | 9.48 | 1,010,816 |
| 2013-11-19 | FIO | Fusion-io, Inc. | Option Ex | 15,000 | .00 | 0 |
| 2013-11-20 | DATA | Tableau Software Inc | Sale | 1,152,625 | 62.73 | 72,298,403 |
| 2013-11-14 | EPZM | Epizyme, Inc. | Buy | 357,000 | 19.98 | 7,132,860 |
| 2013-11-15 | EPZM | Epizyme, Inc. | Buy | 49,500 | 19.81 | 980,496 |
| 2013-11-13 | DATA | Tableau Software Inc | Sale | 6,756,077 | 62.73 | 423,774,929 |
| 2013-11-05 | ADNC | Audience Inc | Sale | 2,573 | 9.83 | 25,287 |
| 2013-08-15 | GRPN | Groupon, Inc. | Sale | 33,903 | 9.78 | 331,605 |
| 2013-06-05 | EPZM | Epizyme, Inc. | Buy | 400,000 | 15.00 | 6,000,000 |
| 2013-06-05 | TSRO | Tesaro, Inc. | Sale | 4,296 | 39.44 | 169,447 |
| 2013-05-22 | DATA | Tableau Software Inc | Sale | 2,000,000 | 28.83 | 57,660,000 |
| 2013-04-16 | OMTH | Omthera Pharmaceuticals, Inc. | Buy | 625,000 | 8.00 | 5,000,000 |
| 2013-04-16 | OMTH | Omthera Pharmaceuticals, Inc. | Sale | 196 | 8.00 | 1,568 |
| 2013-03-07 | ADNC | Audience Inc | Sale | 2,999 | 12.87 | 38,606 |
| 2012-11-27 | FIO | Fusion-io, Inc. | Sale | 971 | 24.15 | 23,449 |
| 2012-10-29 | MM | Millennial Media Inc. | Sale | 1,597,787 | 13.44 | 21,479,050 |
| 2012-09-05 | FIO | Fusion-io, Inc. | Sale | 66,820 | 27.78 | 1,856,059 |
| 2012-07-31 | HPTX | Hyperion Therapeutics Inc | Buy | 500,000 | 10.00 | 5,000,000 |
| 2012-07-03 | TSRO | Tesaro, Inc. | Buy | 1,111,111 | 13.50 | 14,999,998 |
| 2012-04-30 | FIO | Fusion-io, Inc. | Sale | 3,402 | 25.87 | 88,009 |
| 2012-05-01 | FIO | Fusion-io, Inc. | Sale | 479 | 25.00 | 11,975 |
| 2012-02-29 | INWK | Innerworkings Inc | Sale | 455,360 | 11.42 | 5,199,300 |
| 2012-02-27 | FIO | Fusion-io, Inc. | Sale | 1,465 | 27.89 | 40,866 |
| 2012-02-24 | INWK | Innerworkings Inc | Sale | 334,457 | 11.40 | 3,812,809 |
| 2012-02-23 | INWK | Innerworkings Inc | Sale | 54,849 | 11.75 | 644,366 |
| 2012-02-22 | INWK | Innerworkings Inc | Sale | 253,211 | 11.68 | 2,957,757 |
| 2012-02-06 | FIO | Fusion-io, Inc. | Sale | 23,083 | 23.05 | 532,063 |
| 2012-02-03 | FIO | Fusion-io, Inc. | Sale | 982 | 22.85 | 22,442 |
| 2011-11-28 | FIO | Fusion-io, Inc. | Sale | 1,296,109 | 31.68 | 41,060,733 |
| 2011-11-21 | CLVS | Clovis Oncology, Inc. | Buy | 1,316,299 | 13.00 | 17,111,887 |
| 2011-03-10 | ARYX | Aryx Therapeutics, Inc. | Sale | 4,469,274 | .07 | 326,257 |
| 2010-06-30 | SNSS | Sunesis Pharmaceuticals Inc | Buy | 23,824,451 | .28 | 6,551,724 |
| 2009-03-10 | PLIN | Peplin Inc | Buy | 10,000 | .49 | 4,900 |
| 2009-03-11 | PLIN | Peplin Inc | Buy | 5,218 | .49 | 2,556 |
| 2007-11-12 | INWK | Innerworkings Inc | Sale | 242 | 14.71 | 3,560 |
| 2006-02-08 | ATHR | Atheros Communications Inc | Sale | 30,587 | 18.45 | 564,330 |
| 2005-08-05 | ATHR | Atheros Communications Inc | Sale | 44,178 | 10.14 | 448,053 |
| 2005-08-04 | ATHR | Atheros Communications Inc | Sale | 156,782 | 10.31 | 1,615,952 |
| 2005-07-28 | ATHR | Atheros Communications Inc | Sale | 20,000 | 10.86 | 217,280 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Baskett Forest (10% Owner of Adaptimmune Therapeutics Plc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.